XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.25.3

Asset Acquisition - Assets Acquired and Liabilities Assumed (Detail) - Scale BioScience Inc. Acquisition $ in Thousands | Aug. 11, 2025 USD ($)
--- | ---
Asset Acquisition [Line Items] |
Cash | $ 1,390
Developed technology | 51,639
Other assets and liabilities, net | (6,467)
Net identifiable assets acquired | $ 46,562

X
- Definition Asset Acquisition, Assets Acquired and Liabilities Assumed, Net + References No definition available. + Details
Name: | txg_AssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet
Namespace Prefix: | txg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Asset Acquisition, Assets And Liabilities, Other + References No definition available. + Details
Name: | txg_AssetAcquisitionAssetsAndLiabilitiesOther
Namespace Prefix: | txg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Asset Acquisition, Cash and Cash Equivalents + References No definition available. + Details
Name: | txg_AssetAcquisitionCashAndCashEquivalents
Namespace Prefix: | txg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Asset Acquisition, Developed Technology + References No definition available. + Details
Name: | txg_AssetAcquisitionDevelopedTechnology
Namespace Prefix: | txg_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=txg_ScaleBioScienceInc.AcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |